WUXIF
Price
$14.00
Change
-$2.80 (-16.67%)
Updated
Sep 25 closing price
Capitalization
44.18B
ZTEK
Price
$0.85
Change
-$0.02 (-2.30%)
Updated
Sep 25 closing price
Capitalization
89.27M
Interact to see
Advertisement

WUXIF vs ZTEK

Header iconWUXIF vs ZTEK Comparison
Open Charts WUXIF vs ZTEKBanner chart's image
Wuxi Apptec
Price$14.00
Change-$2.80 (-16.67%)
Volume$166
Capitalization44.18B
Zentek
Price$0.85
Change-$0.02 (-2.30%)
Volume$116.13K
Capitalization89.27M
WUXIF vs ZTEK Comparison Chart in %
Loading...
WUXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
WUXIF vs. ZTEK commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is WUXIF is a Hold and ZTEK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (WUXIF: $14.00 vs. ZTEK: $0.85)
Brand notoriety: WUXIF and ZTEK are both not notable
WUXIF represents the Medical Specialties, while ZTEK is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: WUXIF: 58% vs. ZTEK: 30%
Market capitalization -- WUXIF: $44.18B vs. ZTEK: $89.27M
WUXIF [@Medical Specialties] is valued at $44.18B. ZTEK’s [@Pharmaceuticals: Other] market capitalization is $89.27M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.34B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

WUXIF’s FA Score shows that 2 FA rating(s) are green whileZTEK’s FA Score has 0 green FA rating(s).

  • WUXIF’s FA Score: 2 green, 3 red.
  • ZTEK’s FA Score: 0 green, 5 red.
According to our system of comparison, WUXIF is a better buy in the long-term than ZTEK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

WUXIF’s TA Score shows that 4 TA indicator(s) are bullish while ZTEK’s TA Score has 4 bullish TA indicator(s).

  • WUXIF’s TA Score: 4 bullish, 2 bearish.
  • ZTEK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, WUXIF is a better buy in the short-term than ZTEK.

Price Growth

WUXIF (@Medical Specialties) experienced а -16.67% price change this week, while ZTEK (@Pharmaceuticals: Other) price change was -8.70% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.65%. For the same industry, the average monthly price growth was +2.63%, and the average quarterly price growth was +23.73%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.51%. For the same industry, the average monthly price growth was -3.36%, and the average quarterly price growth was +8.17%.

Industries' Descriptions

@Medical Specialties (-2.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-2.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WUXIF($44.2B) has a higher market cap than ZTEK($89.3M). WUXIF YTD gains are higher at: 105.580 vs. ZTEK (-9.574). WUXIF has higher annual earnings (EBITDA): 19.8B vs. ZTEK (-8.14M). WUXIF has more cash in the bank: 24.4B vs. ZTEK (2.89M). ZTEK has less debt than WUXIF: ZTEK (1.88M) vs WUXIF (7.52B). WUXIF has higher revenues than ZTEK: WUXIF (42.8B) vs ZTEK (925K).
WUXIFZTEKWUXIF / ZTEK
Capitalization44.2B89.3M49,496%
EBITDA19.8B-8.14M-243,215%
Gain YTD105.580-9.574-1,103%
P/E Ratio20.75N/A-
Revenue42.8B925K4,627,027%
Total Cash24.4B2.89M844,583%
Total Debt7.52B1.88M400,640%
FUNDAMENTALS RATINGS
ZTEK: Fundamental Ratings
ZTEK
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
WUXIFZTEK
RSI
ODDS (%)
Bullish Trend 1 day ago
8%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
30%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
41%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
41%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
46%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
43%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
32%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
WUXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KCLI32.75N/A
N/A
Kansas City Life Insurance Co.
MKTDF0.06N/A
N/A
Deepmarkit Corp.
LOIMF42.85N/A
N/A
Loomis AB
CSPCY4.73-0.05
-0.94%
CSPC Pharmaceuticals Group Ltd.
LSBCF0.73-0.07
-8.74%
LakeShore Biopharma Co., Ltd.

WUXIF and

Correlation & Price change

A.I.dvisor tells us that WUXIF and BRSYF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WUXIF and BRSYF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WUXIF
1D Price
Change %
WUXIF100%
-16.67%
BRSYF - WUXIF
27%
Poorly correlated
N/A
FDMDF - WUXIF
23%
Poorly correlated
+30.00%
ADMT - WUXIF
22%
Poorly correlated
N/A
USAQ - WUXIF
13%
Poorly correlated
N/A
ZTEK - WUXIF
7%
Poorly correlated
-2.30%
More

ZTEK and

Correlation & Price change

A.I.dvisor tells us that ZTEK and TLTFF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZTEK and TLTFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTEK
1D Price
Change %
ZTEK100%
-2.30%
TLTFF - ZTEK
27%
Poorly correlated
+1.03%
VERO - ZTEK
25%
Poorly correlated
+0.43%
RVTY - ZTEK
25%
Poorly correlated
-1.72%
NVNO - ZTEK
25%
Poorly correlated
-1.77%
INGN - ZTEK
23%
Poorly correlated
+0.36%
More